HIV Prevention Trials Network Awarded U.S. National Institutes of Health Funding to Continue Research Agenda

    NEXT STORY
    Junshi Biosciences Announces Dosing of First Patient in Phase I Study of Anti-TROP2 Antibody -TUB196 Conjugate
    PREV STORY
    Amarin Files Patent Infringement Lawsuit Against Hikma
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novartis announces study data demonstrating Cosentyx® reduced signs and symptoms of psoriatic arthritis while inhibiting progression of joint structural damage

    Structural joint damage in psoriatic arthritis (PsA) patients taking Cosentyx® (secukinumab) was inhibited at ...

    author_avatar
    NASDAQ Market News

    VBL Therapeutics Announces Year Ended December 31, 2018 Financial Results and Provides Corporate Update

    author_avatar
    NASDAQ Market News

    Independence Blue Cross announces new telemedicine coverage

    PHILADELPHIA, March 14, 2016 (GLOBE NEWSWIRE) -- Independence Blue Cross (Independence) announced that it ...

    author_avatar
    NASDAQ Market News